The effect of experimental warming on reproductive performance and parental care in the burying beetle .

R Soc Open Sci

International Degree Program in Climate Change and Sustainable Development, National Taiwan University, Taipei 10617, Taiwan.

Published: October 2024

Rising temperatures can adversely affect parental care and reproductive performance across a range of taxa. However, the warming impact is contingent upon understanding how temperature affects the spectrum of parental behaviours and their interplay. Here, we assessed how temperature affects parental care and reproductive success in the burying beetle, , which exhibits complex parental care behaviours. We exposed breeding pairs of , to three temperature regimes (18°C, 20°C and 22°C) and assessed changes in parental care, and the subsequent development and growth of their offspring. Our findings show that 22°C disrupts carcass nest building by the parents and results in smaller clutches. Moreover, no eggs successfully hatched in the 22°C treatment. A milder increase to 20°C did not affect the hatching rate but resulted in smaller broods and lighter offspring, even when considering brood size, suggesting a change in post-hatching care quality. Our research suggests that warming may weakly affect parental care but has strong detrimental effects on offspring performance. These findings highlight the necessity of investigating the effect of ambient temperature across a diversity of traits and behaviours and across a range of life-history stages to fully assess species vulnerability in the face of future climate change.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11461049PMC
http://dx.doi.org/10.1098/rsos.240653DOI Listing

Publication Analysis

Top Keywords

parental care
24
reproductive performance
8
burying beetle
8
affect parental
8
care reproductive
8
parental
7
care
7
experimental warming
4
warming reproductive
4
performance parental
4

Similar Publications

Hospital in-reach family-centred social prescribing pilot for children with neurodisability: mixed methods evaluation with social return on investment analysis.

BMC Health Serv Res

January 2025

Population Health Sciences Institute, Newcastle University, Level 3, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK.

Background: Social prescribing link workers support individuals to engage with community resources, co-creating achievable goals. Most schemes are community-based, targetting adults. Vulnerable populations including hospitalized children with neurodisability and their families, could also benefit from social prescribing.

View Article and Find Full Text PDF

Background: Sexual and reproductive health issues in adolescents living with HIV (ALHIV) have been left behind in HIV care programs. ALHIV are at risk of unintended pregnancy which jeopardizes their socio-economic future, health outcomes and exposes their newborn to HIV transmission. A better understanding of these events is needed.

View Article and Find Full Text PDF

Background: Colic in infants is defined as excessive crying in an otherwise healthy and thriving baby. Colic is a common but poorly understood and often frustrating problem for caregivers.

Objective: To study whether osteopathic treatments of infants with infantile colic / excessive crying (IC/EC) have an impact on the subjectively perceived psychological stress of caregivers compared to usual care.

View Article and Find Full Text PDF

Pediatric non-alcoholic fatty liver disease (NAFLD) is emerging as a worldwide health concern with the potential to advance to cirrhosis and liver cancer. NAFLD can also directly contribute to heart problems through inflammation and insulin resistance, even in individuals without other risk factors. The pathological mechanisms of NAFLD are linked to functional differences of miRNAs in different biological environments.

View Article and Find Full Text PDF

Background: Cystic fibrosis (CF) is associated with a historically high treatment burden which causes anxiety and exhaustion for parents of children with CF, especially in the early years of a child's life. Recently, a new medication, elexacaftor/tezacaftor/ivacaftor (ETI), has become available to some people with CF, which has had a significant impact on the quality of life of older children and adults. This medication will soon be available for children ages 2-5 in the UK.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!